Home » Topics » BioWorld Science

BioWorld Science
RSS

Cardioprotective and vasodilating effects described for JTV-519 at ASA meeting

Oct. 15, 2001

Potential new therapeutic target for endotoxin shock: anandamide

Oct. 15, 2001

Cardioprotective effects of landiolol and propranolol compared in guinea pig hearts

Oct. 15, 2001

MGI Pharma expands phase II irofulven clinical trial in ovarian cancer

Oct. 15, 2001

GlycoDesign and Leo move new antithrombotics into clinical trials

Oct. 15, 2001

First clinical data for new propofol prodrug presented at ASA meeting

Oct. 15, 2001

Favorable OvaRex/chemotherapy clinical trial results in relapsed ovarian cancer reported by AltaRex

Oct. 15, 2001

Matrix to initiate new study of tezacitabine in AML

Oct. 15, 2001

High-dose ISIS-2302 enemas improve symptoms in ulcerative colitis

Oct. 15, 2001

Gene therapy with IL-10 produces therapeutic benefit in experimental colitis

Oct. 15, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...